NASDAQ:DARE   Dare Bioscience, Inc.
Dare Bioscience shares are trading higher on an unconfirmed rumor that Brookline Capital has initiated a Buy rating on the stock with a $7.50 price target. source Benzinga

⭐⭐⭐ Sign Up for Free ⭐⭐⭐

1) Download our Mobile App >>

Android: dexwirenews.com/APP

Apple: dexwirenews.com/iOS

2) Join our Telegram >> t.me/DEXWireNews

3) Follow @DEXWireNews on Social Media
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.